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Abstract
Apurinic/apyrimidinic endonuclease 1 (APE1), a ubiquitous multipurpose protein, is also known as redox effector factor-1
(Ref-1). It is involved in DNA repair and redox signaling and, in turn, oxidative stress-induced neurodegeneration.
Although previous studies have demonstrated that APE1/Ref-1 functions as a negative regulator of inflammatory
response via several mechanisms in neuronal cells, little is known about the roles of APE1/Ref-1 in glial cells. In
this study, we found that cytoplasmic APE1/Ref-1 expression was upregulated in reactive astrocytes of the kainic
acid- or lipopolysaccharide (LPS)-injected hippocampus. Analysis of the inflammatory response induced by extranuclear
APE1/Ref-1 (ΔNLS-Ref-1) in cultured primary astrocytes revealed that it markedly suppressed inducible nitric oxide
synthase (iNOS) expression and tumor necrosis factor-α (TNF-α) secretion induced by LPS to a similar extent as did wild
type APE1/Ref-1 (WT-Ref-1), supporting the concept an anti-inflammatory role of extranuclear APE1/Ref-1 in astrocytes.
Additionally, overexpression of WT- and ΔNLS-Ref-1 suppressed the transcriptional activity of nuclear factor-κB (NF-κB),
although it effectively enhanced activator protein 1 (AP-1) activity. The blunting effect of APE1/Ref-1 on LPS-induced
NF-κB activation was not mediated by IκB kinase (IKK) activity. Instead, APE1/Ref-1 inhibited p300-mediated acetylation
of p65 by suppressing intracellular reactive oxygen species (ROS) levels following LPS treatment. Taken together, our
results showed that altered expression and/or subcellular distribution of APE1/Ref-1 in activated astrocytes
regulated the neuroinflammatory response to excitotoxin and endotoxin insults used in model of
neurodegenerative brain diseases.
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Introduction
Apurinic/apyrimidinic endonuclease 1 (APE1), a ubiqui-
tous multipurpose nuclear protein, is involved in the
base excision repair pathway for damaged bases and
DNA single-strand breaks following endogenous and ex-
ogenous oxidative stress. APE1 acts as a reductive activa-
tor of many transcription factors involved in apoptosis,
inflammation, angiogenesis and survival pathways [1–4],
and also known as redox effector factor-1 (Ref-1). APE1/
Ref-1 is highly expressed in vivo in specific brain regions,
such as the hippocampus and cerebral cortex [5, 6]. It
plays a neuroprotective role in brain pathology character-
ized by increased inflammation and oxidative stress, such
as ischemic [7, 8] or compression injury [9] and neurode-
generation [10–12]. Astrocytes, the most numerous non-
neuronal cell type, comprise ~50% of human brain volume
[13], and express high levels of APE1/Ref-1. However, des-
pite the wealth of information available on neuronal APE1/
Ref-1 in brain diseases, the functional significance of APE1/
Ref-1 in glial cells is unclear.
In addition to its classical role as a nuclear protein, ex-
tranuclear APE1/Ref-1 controls the intracellular redox
state by inhibiting reactive oxygen species (ROS) produc-
tion via negative regulation of the activity of Rac1, a Ras-
related GTPase [14]. The cytoplasmic/nuclear distribution
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appears to fine tune the anti-inflammatory activity of
APE1/Ref-1 [15, 16]. Astrocytes are important sources of
proinflammatory mediators, such as inducible nitric oxide
synthase (iNOS) and tumor necrosis factor-α (TNF-α),
which modulate various brain pathophysiologies [17–19].
Astrocytic APE1/Ref-1, especially extranuclear APE1/Ref-1,
may regulate neuroinflammatory process in the brain. Here
we show that cytoplasmic APE1/Ref-1 inhibited the iNOS
expression and TNF-α secretion of reactive astrocytes in
the excitotoxin- and endotoxin-challenged brain, at least in
part by negatively regulating ROS and NF-κB signaling.
Results
Changes in APE1/Ref-1 expression and subcellular
translocation in reactive astrocytes
Previous studies demonstrated that APE1/Ref-1 expression
was increased in both surviving and vulnerable neurons
following inflammatory insults [7, 20]. To assess whether
this is also the case in reactive astrocytes, we investigated
APE1/Ref-1 expression in astrocytes from kainic acid
(KA)- or lipopolysaccharide (LPS)-treated brains.
KA treatment resulted in a clear pattern of behavioral
seizures that began within 20 min after the injection,
and progressed to tonic-clonic activity. KA-induced exci-
totoxicity has been used as a model for examining
mechanisms underlying oxidative stress and inflamma-
tion. Thus, APE1/Ref-1 expression was compared in
control and KA-treated brains. APE1/Ref-1-immuno-
reactivity (ir) consisted of nuclei from neurons and
astrocytes in KA-vulnerable regions, including the
hippocampal principle neuronal layers and hilar sub-
regions. While most APE1/Ref-1-ir was in neurons in
both the control and KA-treated groups, APE1/Ref-1
positive cells exhibited glial morphology with small
nuclei and short processes, or faintly stained nuclei
and dense cytoplasm, especially in hilar region of KA-
treated brains (Fig. 1a). Double immunofluorescence
staining showed that APE1/Ref-1-ir was increased in
glial fibrillary acidic protein (GFAP)-positive cells in
the CA3 region of KA-treated hippocampi. APE1/Ref-
1-positive astrocytes increased at 1 d post-lesion, be-
came maximal at 3 d, and recovered to control level
by 7 d after KA-injection (Fig. 1b). Furthermore,
APE1/Ref1-ir was found in the processes and cyto-
plasm of astrocytes (Fig. 1c). The Western blot analysis
showed that there was a tendency for APE1/Ref-1 levels
to increase in the whole hippocampus in KA-treated
groups (data not shown), but this did not reach statistical
significance at 1-7 d after KA-injection (p > 0.1). Double
immunofluorescence staining showed that reactive astro-
cytes expressed iNOS in the KA-treated hippocampus
(Fig. 1d). These results indicated that cytoplasmic APE1/
Ref-1 expression was upregulated in reactive astrocytes
under KA-induced oxidative stress and inflammatory
conditions.
To assess if our observation was generalizable, we
also examined the subcellular distribution of APE1/Ref-
1 expression in an LPS-challenged in vivo model. Cyto-
plasmic translocation of APE1/Ref-1 in astrocytes was
also observed in the LPS-treated brain. APE1/Ref-1-ir
was clearly detected in the processes and cytoplasm of
reactive astrocytes after LPS treatment (Fig. 1e), which
increased significantly in the CA3 regions of the LPS-
treated hippocampus (Fig. 1f ).
Ectopic expression of APE1/Ref-1 abrogates inflammatory
responses in primary cultured astrocytes
To investigate whether APE1/Ref-1 is involved in the in-
flammatory response, primary cultured astrocytes that
showed high APE1/Ref-1 expression in in vivo experi-
ments above were infected with AdRef-1.
In agreement with previous reports [21–24], LPS in-
duced iNOS expression in cultured astrocytes (Fig. 2a).
LPS treatment resulted in a rapid and progressive induc-
tion of iNOS expression and TNF-α production in a
time-dependent manner, while the basal levels of these
inflammatory mediators were barely detectable in con-
trol cells (Fig. 2b), indicating that inflammatory reactions
can be triggered effectively in this primary cells. Remark-
ably, overexpression of APE1/Ref-1 almost completely
blocked LPS-induced iNOS expression and TNF-α pro-
duction (Fig. 2c, d). This indicated that APE1/Ref-1 was
able to downregulate the LPS-induced inflammatory re-
sponse in primary astrocytes.
To confirm the role of endogenous APE1/Ref-1 against
the inflammatory response to LPS, we next examined the
extent of LPS-induced iNOS and TNF-α production in
APE1/Ref-1 knocked-down primary astrocytes using spe-
cific small interfering RNA (siRNA). Consistently, APE1/
Ref-1 knockdown resulted in significantly enhanced iNOS
expression and TNF-α production induced by LPS, versus
that in cells treated with scrambled RNA or uninfected
control cells (Fig. 2e, f ). These results suggest that APE1/
Ref-1 has the capacity to downregulate the LPS-induced
inflammatory response in reactive astrocytes.
Role of cytoplasmic APE1/Ref-1 against the LPS-induced
inflammatory response in primary cultured astrocytes
Certain conditions, including inflammation, lead to
APE1/Ref-1 translocation from the nucleus into the
cytoplasm, which is critical for APE/Ref-1 activity [25].
Having shown that increased APE1/Ref-1 was localized
in the cytoplasm of reactive astrocytes in both KA- and
LPS-challenged brains (Fig. 1), we next examined the
functional significance of cytoplasmic APE1/Ref-1 in as-
trocytes activated by inflammatory insults. To address
this, we generated and transiently transfected a mutant
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construct of APE1/Ref-1 (ΔNLS-Ref-1), which lacked
the N-terminal nuclear import sequence (NLS), in pri-
mary cultured astrocytes. Consistent with our previous
report [16], ΔNLS-Ref-1 was localized exclusively in the
cytoplasm, while the majority of wild-type APE1/Ref-1
(WT-Ref-1) expression was in the nucleus (data not
shown).
LPS-induced iNOS expressions was markedly sup-
pressed in ΔNLS-Ref-1-transfected astrocytes (Fig. 3a, b).
Consistent with this, ΔNLS-Ref-1 was able to suppress
LPS-induced TNF-α secretion to a degree similar to that
obtained with WT-Ref-1 (Fig. 3c). Combined with the
enhanced expression of cytoplasmic APE1/Ref-1 in the
proinflammatory injured brain, these observations sug-
gest that, in the cytoplasm, APE1/Ref-1 functions as an
important negative regulator to suppress inflammatory
reactions.
Extra-nuclear APE1/Ref-1 acts as a negative regulator of
NF-κB signaling without affecting IκB kinase activity
It has been established that NF-κB activation is an es-
sential process for the transcriptional induction of proin-
flammatory cytokines including iNOS and TNF-α. To
determine the molecular mechanism involved in the
APE1/ref-mediated anti-inflammatory response, we next
examined whether the expression levels of APE1/Ref-1
affect the transcriptional activity of NF-κB.
Ectopic overexpression of APE1/Ref-1 (WT-Ref-1 and
ΔNLS-Ref-1) resulted in a significant decrease of NF-κB
activity in response to LPS (Fig. 4a). Consistently, APE1/
Ref-1 knockdown resulted in a marked increase in NF-
κB reporter activity induced by LPS (Fig. 4b). In contrast
to anti-NF-κB properties of APE1/Ref-1, LPS-induced
AP-1 activation was significantly enhanced by overex-
pression of the wild-type and ΔNLS forms of APE1/Ref-
1 (Fig. 4c). This indicate that ΔNLS-Ref-1 was able to
downregulate NF-κB signaling to a similar extent as did
WT-Ref-1, whereas it upregulated AP-1 transcriptional
activity. Confirming this, NF-κB activation, mediated by
the NF-κB component (p65), IκB kinase β (IKKβ) and
adaptor proteins (MyD88, TRAF6) was also significantly
attenuated by ΔNLS-Ref-1 in 293/TLR4/IL-1R cells sta-
bly expressing TLR4 and IL-1R (Fig. 4d).
To gain insight into the specificity of the molecular
mechanisms underlying NF-κB regulation by APE1/Ref-1,
we further analyzed the IKK-mediated phosphorylation/
degradation of IκBα. Unexpectedly, wild-type- and ΔNLS-
Ref-1 failed to downregulate the phosphorylation and deg-
radation of IκBα, whereas both types of APE1/Ref-1 were
able to enhance the phosphorylation of c-jun N-terminal
kinase (JNK) and extracellular signal-regulated kinase
(ERK) in response to LPS (Fig. 4e). These results indicated
that downregulation of LPS-induced NF-κB activation by
Ref-1 was independent of IKK. Consistently, LPS-induced
IKK activity was not affected by wild-type- or ΔNLS-Ref-1
overexpression (Fig. 4f), confirming that APE1/Ref-1 likely
functions downstream of IKK signaling components in
downregulating NF-κB transcriptional activity.
Ref-1 abolishes p300-mediated p65 acetylation via
suppression of cellular ROS levels
Because it seemed that the inhibitory mechanism of
APE1/Ref-1 on LPS-induced NF-κB activation was not
associated with IKK activity, we next examined whether
APE1/Ref-1 affected the acetylation status of the p65
subunit of NF-κB, an important event in the transcrip-
tional activation of NF-κB. To address this, the primary
cultured astrocytes were treated with LPS for different
time points, and cell extracts were collected for immu-
noprecipitation experiments with anti-p65 antibodies.
We found that endogenous acetylation of p65 was de-
tectable in the immunoprecipitates, peaking at 30-min
post LPS treatment (Fig. 5a, top panel, left). This LPS-
induced acetylation of p65 was abolished in APE1/Ref-1
overexpressing cells without altering phosphorylation
levels, even though comparable amounts of total p50
were immunoprecipitates in each sample (Fig. 5a, top to
third panel). These results suggest that the inhibitory
(See figure on previous page.)
Fig. 1 Altered APE1/Ref-1 expression in the kainic acid (KA)-injured hippocampus. a APE1/Ref-1 immunoreactivity in the hippocampus at 1, 3, and
7 d after KA injection. Higher magnification of areas in CA3 region of the hippocampus showed sequential changes of APE1/Ref-1 expression
(lower panel; scale bar = 20 μm). Note that APE1/Ref-1-ir appeared in small nuclei and short processes (glial morphology, white arrowheads), or
faint nuclei and dense cytoplasm (white arrows) in KA treated hippocampus, while it mostly appeared in the round nuclei in control brain (blue
arrowheads). b Representative photomicrographs from the double immunofluorescence staining for APE1/Ref-1 (red) and GFAP (green) in the CA3
region of KA-treated hippocampi (3 d after KA injection). APE1/Ref-1 was found in the processes (white arrowheads) and perinuclear cytoplasm
(white arrows) of GFAP-positive astrocytes. Nuclei were counterstained with DAPI (blue). c Quantitative analysis of double immunofluorescence
staining for the identification of APE1/Ref-1-positive cells in the KA-injured hippocampus. The portion of APE1/Ref-1-positive cells out of total glial
fibrillary acidic protein (GFAP)-positive cells was compared at 1, 3, and 7 d in the KA-injured hippocampus. ***P ˂ 0.001 vs. saline-injected control.
d Representative photomicrographs showing that GFAP-positive cells expressed iNOS in the KA-treated groups. Nuclei were counterstained with
DAPI (blue). e Representative photomicrographs showing that APE1/Ref-1 was expressed in reactive astrocytes in the LPS-treated hippocampi (1 d
after LPS injection). APE1/Ref-1 was found in the processes and cytoplasm of GFAP-positive astrocytes (white arrowheads). Nuclei were counter-
stained with DAPI (blue). Scale bar = 200 μm (or 20 μm, in set). f Quantitative analysis of double immunofluorescence staining for the identification
of APE1/Ref-1-positive cells in the LPS-injured hippocampus. ***P ˂ 0.05 vs. saline-injected control
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potency of APE1/Ref-1 with regard to p65 acetylation
contributes to downregulating the LPS-induced NF-κB
response.
To confirm these observations, we compared the ability
of wild-type- and ΔNLS-Ref-1 to regulate p65 acetylation
induced by the overexpression of p300 acetyltransferase,
which has an essential role in p65 acetylation through a
physical interaction. Consistent with previous reports
[26, 27], overexpression of p300 resulted in a remarked
increase in p65 acetylation, and this p300-mediated
acetylation was almost completely impaired in wild-
type- and ΔNLS-Ref-1-transfected cells (Fig. 5b, top
panel). This suggested that extranuclear APE1/Ref-1
interrupted p300-mediated p65 acetylation, but at early
stage of IKK-mediated p65 phosphorylation.
It has been established that the catalytic activity of
p300 in human cells is directly regulated by the cellular
redox state [28, 29]. Furthermore, convincing evidence
indicates that APE1/Ref-1 controls the level of intracel-
lular ROS, which has been linked to the regulation of
many transcription factors. Therefore, we hypothesized
that the inhibitory effects of wild-type- or ΔNLS-Ref-1
on LPS-induced p65 acetylation might be achieved
through regulation of intracellular ROS levels. As ex-
pected, overexpression of ΔNLS-Ref-1 significantly
blunted LPS-induced ROS production to a similar extent
as did wild type-Ref-1 (Fig. 5c, d). Furthermore, treat-
ment with the ROS scavenger N-acetyl-L-cysteine
(NAC), markedly suppressed p300-mediated p65 acetyl-
ation under conditions of ectopic expression of ΔNLS-
Fig. 2 APE1/Ref-1 inhibits LPS-induced iNOS expression and TNF-α secretion in primary cultured astrocytes. a Representative photomicrographs
showing that LPS treatment induced iNOS expression in cultured astrocytes. Scale bar = 20 μm. b LPS increases iNOS expression and TNF-α secretion
from cultured astrocytes in a time-dependent manner. Cells and media were harvested after treatment with LPS (100 nM) for the indicated
times. c Western blot analysis for APE1/Ref-1 and iNOS was performed at 24 h on LPS-treated cells. Ectopic expression of APE1/Ref-1 using
APE1/Ref-1 adenovirus (AdRef-1) inhibited LPS-stimulated iNOS expression. d Summarized data showing that APE1/Ref-1 inhibited LPS-induced iNOS
expression (left) and TNF-α secretion (right). Data represent the mean ± standard error of mean (SEM; n = 4). ** p < 0.01 vs. non-transfected control cells;
## p < 0.01 vs. β-galactosidase virus (Adβgal)-transfected control cells by a two-way anaysis of variance (ANOVA) followed by Dunnett’s test. e Reduced
APE1/Ref-1 expression by short interfering RNA (siRNA; 100 pmol) significantly enhanced LPS-induced iNOS expression. f Summarized data showing
that siRNA for APE1/Ref-1 (siRef-1) increased LPS-induced iNOS expression (left) and induced TNF-α secretion (right) in astrocytes. Data represent the
mean ± SEM of four separate experiments. **, ## p < 0.01 vs. non-transfected control cells and scrambled RNA (siCon) by two-way ANOVA, followed by
Dunnett’s test, respectively
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Ref-1 or knocked-down expression of APE1/Ref-1
(Fig. 5e). Therefore, these findings suggest that cytoplas-
mic APE1/Ref-1 is able to effectively suppress LPS-
induced p65 acetylation via its antioxidant role, acting as
a negative regulator of NF-κB signaling.
Discussion
The main findings of the present study were as follows:
1) APE1/Ref-1 expression with cytoplasmic translocation
was increased in reactive astrocytes in hippocampi
treated with KA or LPS; 2) both wild-type APE1/Ref-1
and ΔNLS-Ref-1 acted as negative regulators of the in-
flammatory response in primary cultured astrocytes,
while APE1/Ref-1 knockdown significantly enhanced the
inflammatory response; and 3) WT- and ΔNLS-Ref-1
blunted p300-mediated p65 acetylation without altering
the phosphorylation status via their antioxidant proper-
ties, leading to NF-κB inhibition. Our findings provide
the first evidence that cytoplasmic APE1/Ref-1 regulates
excitotoxin- and endotoxin-induced neuroinflammatory
events in brain reactive astrocytes via NF-κB dependent
pathway.
While APE1/Ref-1 is highly expressed in proliferating
cells during embryonic and early postnatal development
in the hippocampus and piriform cortex [30, 31],
APE1/Ref-1 expressed to a less extent in the adult
brain, particularly in astrocytes [5]. In the present
study, the principle neuronal layers of the hippocampus
consistently showed much higher immunoreactivity
than the surrounding areas in the normal brain (Fig. 1a).
However, we observed the significantly enhanced
APE1/Ref-1 expression in the cytoplasm of proinflam-
matory mediator-induced reactive astrocytes in brains
injured with KA or LPS. Furthermore, overexpression
of extranuclear APE1/Ref-1 blocked the LPS-induced
inflammatory response in primary cultured astrocytes.
Thus, enhanced cytoplasmic expression of APE1/Ref-1
in reactive astrocytes may act as a negative regulator to
prevent excessive inflammatory reactions such as iNOS
expression and TNF-α secretion.
APE1/Ref-1 may play a role in immunocompetent cells
of the brain during aluminum chloride (AlCl3)-induced
neuroinflammation, which could be prevented by treat-
ment with resveratrol [32]. When resveratrol reversed
AlCl3-induced neuroinflammation, increased APE1/Ref-
1 coincide with reduced expression of TNF-α, IL-6 and
iNOS in the brain. Combined with the finding that AlCl3
induced the production of proinflammatory cytokines
and NO in both microglia and astrocytes [33], Zaky et
al. suggested a role for glial APE1/Ref-1 in the
resveratrol-mediated inhibition of neuroinflammation
[32]. However, the neuronal affects were not differenti-
ated from the glial effects in the resveratrol-induced
anti-inflammatory response. In the current study, we
provide direct evidence that increased cytoplasmic
APE1/Ref-1 contributes to anti-inflammatory processes
Fig. 3 N-terminus deletion mutant APE1/Ref-1 (ΔNLS-Ref-1) inhibits LPS-induced iNOS expression and TNF-α secretion in astrocytes. a Western
blot analysis showing the effects of ΔNLS-Ref-1 expression by plasmid transfection on LPS-induced iNOS expression. b Summarized data showing
the ΔNLS-Ref-1 inhibition of LPS-induced iNOS expression, as in A. Data represent the mean ± SEM (n = 4). c Effects of wild-type (WT-Ref-1) and
ΔNLS-Ref-1 overexpression on LPS-induced TNF-α secretion from astrocytes. Data represent the mean ± SEM of three separate experiments. ** p < 0.01
vs. non-transfected control cells
Baek et al. Molecular Brain  (2016) 9:99 Page 6 of 12
in reactive astrocytes during neuroinflammation in the
brain.
While the expression of APE1 is primarily nuclear,
APE1/Ref-1 undergoes active shuttling between the
cytoplasm and the nucleus depending on the cell type
and certain pathological conditions, including oxidative
stress and inflammation [14, 34, 35]. Although the sub-
cellular localization of APE1/Ref-1 is commonly associ-
ated with the redox state of the cysteine residues of
APE1/Ref-1 [16, 36], the functional role of APE1/Ref-1
Fig. 4 APE1/Ref-1 regulates LPS-mediated NF-κB signaling without affecting IKK activity. a, b Primary cultured astrocytes were transfected with
p2xNF-κB-Luc and pRSV-β-gal with expression plasmids for the flag-tagged APE1/Ref-1 (wild-type- and ΔNLS-Ref-1) or APE1/Ref-1 short interfering
RNA (siRef-1; 100 pmol). c Primary cultured astrocytes were transfected with the expression plasmids of the p2xTRE-Luc, pRSV-β-gal, WT-, and
ΔNLS-Ref-1. After 24 h of transfection, cells were treated with LPS (1 μg/mL) for 6 h. d 293/TLR4/IL-1R cells were transiently transfected with the
expression plasmids indicated, along with p2xNF-κB-Luc and pRSV-β-gal. Luciferase assays were performed as described in the Methods, and the
activity of each sample was normalized according to the β-galactosidase activity. Each column shows the mean ± SEM of at least three independent
experiments. *p ˂ 0.05 vs. mock-transfected cells. e, f 293/TLR4/IL-1R cells were transiently transfected with either wild-type- or ΔNLS-Ref-1 for 24 h, and
then cells were treated with LPS for the times indicated. Whole-cell lysates were immunoblotted with the indicated antibodies (e). Cell extracts were
subjected to immunoprecipitation with an anti-IKK-γ antibody, and its activity was assessed by an immune complex kinase assay, as described
in the Methods (f, upper panel). The specificity of the immunoprecipitation of the IKK complex was confirmed by immunoblotting with an
anti-IKK-γ antibody (f, lower panel)
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in the inflammatory process varies by cell types. For ex-
ample, the cytoplasmic localization of APE1/Ref-1 was
associated with its anti-Inflammatory activity in mono-
cytes and endothelial cells [37, 38]. In contrast,
pharmacological inhibition of APE1/Ref-1 suppressed
the inflammatory response in activated macrophages
[39]. The cytoplasmic APE1/Ref-1 localization mediating
an anti-inflammatory response is consistent with ROS
Fig. 5 APE1/Ref-1 suppresses p300-mediated p65 acetylation via suppressing cellular ROS levels. a Primary cultured astrocytes were transiently
transfected with wild-type- or ΔNLS-Ref-1, followed by LPS treatment for the times indicated. After immunoprecipitation with an anti-p65 antibody,
the acetylation levels of p65 were detected by immunoblotting with an acetyl-lysine-specific antibody (top row). Co-immunoprecipitated p50 served
as a positive control (top second row). Whole-cell lysates were immunoblotted with the antibodies indicated. b 293/TLR4/IL-1R cells were
co-transfected with expression plasmids HA-p65 and Myc-p300 along with flag-tagged wild-type- or ΔNLS-Ref-1. Whole cell lysates were
subjected to immunoblotting with anti-acetyl-p65, HA, Myc, and flag antibodies. c Primary cultured astrocytes were transiently transfected
with either wild-type- or ΔNLS-Ref-1, as described in (a), followed by LPS treatment for 10 min. ROS levels were measured with a flow cytometer (top
panel) as described in the Methods. d Data were processed and quantified with FlowJo software. e 293/TLR4/IL-1R cells were transfected with either
100 pmol of scramble (control; siCon) or APE1/Ref-1 short interfering RNA (SiRef-1) along with the expression plasmids HA-p65 and Myc-p300 in the
absence or presence of NAC (10 mM). Whole-cell lysates were subjected to immunoblotting with the indicated antibodies
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inhibition in endothelial cells [37, 38], while the trans-
location of APE1/Ref-1 from the cytoplasm to nucleus
has been observed with various redox-related stimuli
[35, 40]. In the present study, the prominent cytoplasmic
APE1/Ref-1-ir in vivo was detected only in reactive as-
trocytes (Fig. 1), suggesting a possible role of APE1/Ref-
1 during the neuroinflammatory process in the injured
brain. Furthermore, our results showing that cytoplasmic
APE1/Ref-1, overexpressed with ΔNLS-Ref-1, mimicking
the anti-inflammatory role of wild-type APE1/Ref-1
overexpression in LPS-stimulated cultured astrocytes,
are consistent with cytoplasmic APE1/Ref-1 effectively
mediating the anti-inflammatory response during oxida-
tive stress.
Our results showing that APE1/Ref-1 knockdown re-
sulted in significantly enhanced iNOS expression and
TNF-α production induced by LPS further suggested
that endogenous APE1/Ref-1 paly an anti-inflammatory
role in reactive astrocytes. Given that oxidative stress
and inflammation could elicit either the up-regulation of
expression or the cytoplasmic translocation of APE1/
Ref-1, cytoplasmic translocation of APE1/Ref-1 may not
be essentially depend on the protein synthesis in reactive
astrocytes. Indeed, LPS induced cytoplasmic transloca-
tion of APE1/Ref-1 in cultured astrocytes with minimal
changes in APE/1Ref-1 expression in the present study
(Fig. 2). Similarly, in our previous report [16], TNF-α
induced subcellular translocation rather than de novo
protein synthesis to increase cytoplasmic APE1/Ref-1 in
endothelial cells. However, cellular mechanism(s) for the
cytoplasmic up-regulation of APE1/Ref-1 in inflamed
brain is an open question to be further studied. Fur-
thermore, iNOS expression in reactive astrocytes in
KA-injured brain (Fig. 1) suggested that cytoplasmic
APE1/Ref-1 translocation was not enough to com-
pletely abolish iNOS expression in the brain injury.
Given that various resident and infiltrated inflammatory
cells involve in the inflamed brain [41], APE1/Ref-1
shRNA delivery in specific glial cells would dissect the
anti-inflammatory role of cytoplasmic APE1/Ref-1 in
reactive astrocytes among others.
An important finding of this study was that extranu-
clear APE1/Ref-1 inhibited the transcriptional activity of
NF-κB, even though it efficiently enhanced AP-1 activity.
Earlier biochemical studies revealed that APE1/Ref-1
directly interacted with and reduced p50, a NF-κB sub-
unit, leading to enhanced DNA-binding activity [42, 43].
However, due to lack of APE1/Ref-1-deficient mice, the
exact role of APE1/Ref-1 in NF-κB signaling cascade in
different cells or tissues remains unclear. The redox sta-
tus in cells plays an essential role in NF-κB activation
and nuclear chromatin remodeling (acetylation vs. dea-
cetylation). Thus, one possibility of the discrepancy with
previous report is that, the capacity of APE1/Ref-1 to act
as a redox chaperone might be predominantly involved
in downregulation of NF-κB transcriptional activity in
response to LPS in cells harboring abundant NF-κB sig-
naling machinery such as primary cultured astrocytes or
293/TLR4/IL-1R cells. This interpretation is supported
by the observations that extranuclear APE1/Ref-1 sup-
presses LPS-induced ROS production and p65 acetyl-
ation to a similar extent as wild-type APE1/Ref-1,
without altering IKK activity. Importantly, we found that
such p300-mediated p65 acetylation was masked by
overexpression of both types of APE1/Ref-1 and with
the antioxidant NAC. These findings indicate that
APE1/Ref-1 ensures effective shutdown of p65 acetyl-
ation via modulating intracellular ROS levels within the
nucleus and cytoplasm, suppressing NF-κB transcrip-
tional activity. Nevertheless, how APE1/Ref-1 controls
and regulates the p65 acetylation is a question that re-
mains largely unanswered.
Astrocytes are the main glial cell type in the brain in-
volved in maintaining CNS homeostasis, and respond
promptly to injury and regulate neuroinflammatory
events [44, 45]. Both in vitro and in vivo studies have
documented the ability of astrocytes to produce various
cytokines and chemokines. Proinflammatory cytokines
released from activated glial cells may lead to neuronal
death, causing neuropathological changes in central ner-
vous system (CNS) diseases, such as multiple sclerosis
[46, 47], Parkinson’s disease (PD) [48, 49] and Alzheimer’s
disease (AD) [50]. Our results suggest that extranuclear
APE1/Ref-1 inhibits proinflammatory mediators, includ-
ing iNOS and TNF-α in astrocytes. Therefore, limiting in-
flammatory cytokine production in reactive astrocytes via
APE1/Ref-1 activity expected to be beneficial for the pre-
vention of neuroinflammation and neurodegeneration in
various brain diseases.
In neurodegenerative diseases involving oxidative
DNA damage, such as AD, PD, and amyotrophic lateral
sclerosis (ALS), decreased neuronal expression of APE1/
Ref-1 after neuronal insult decreases cell viability and
promotes neurodegeneration [51]. In addition to the ex-
pression of APE1/Ref-1, alterations in its subcellular
localization reportedly play a role in neurodegenerative
disease. Given that a seizure insult increases oxidative
stress and inflammatory process [52], it is not surprising
that APE1/Ref-1 activity is altered in the epileptic hippo-
campus. Indeed, our results showing that a KA-injection
reduced APE1/Ref-1-ir in pyramidal cell layers (Fig. 1a)
is consistent with a previous report [53]. Our results also
showed that extranuclear translocation of APE1/Ref-1 was
increased in astrocytes of the excitotoxin- and endotoxin-
injured brain, which would reduce the neuroinflammatory
response. To our knowledge, this is the first reported
evidence that the subcellular translocation of APE1/Ref-1
in astrocytes is involved in neuroinflammatory events in
Baek et al. Molecular Brain  (2016) 9:99 Page 9 of 12
the brain diseases, whereas neuronal APE1/Ref-1 has been
linked with various brain oxidative stresses.
Overall, our results are the first reported evidence that
altered subcellular translocation of APE1/Ref-1 in react-
ive astrocytes mediates anti-inflammatory events, thus,




Animals housed under a 12/12-h light/dark schedule had
access to food water ad libitum throughout the experi-
ments. All animal experiments adhered to the Chungnam
National University policies regarding the care and use of
animals. As described previously [54, 55], KA was injected
using a 50-μl Hamilton microsyringe fitted with a 26-
gauge needle (0.1 μg/5 μl in PBS, i.c.v), and LPS was
injected intraperitoneally (10 mg/kg, i.p.). The same vol-
ume of phosphate-buffered saline was injected i.c.v or i.p.
as a respective control.
Immuonohistochemistry and double Immunofluorescence
Sections (25 μm) from post-fixed brains in 4% paraformal-
dehyde were cut using a cryostat as described previously
[56]. Free-floating sections subjected to immunohisto-
chemical staining using the avidin-biotin peroxidase
complex (ABC) method were incubated with primary
anti-APE1/Ref-1 (1:200 dilution). Double immunohisto-
chemical fluorescent reactions were used to study the
expression of APE1/Ref-1 or iNOS, and their possible
colocalization with astroglial cell (glial fibrillary acid pro-
tein, GFAP immunoreactive). Sections were incubated for
24 hs in the presence of a polyclonal rabbit anti APE1/
Ref-1 primary antibody in conjunction with a monoclonal
mouse anti GFAP (1:10,000 dilution) antibody. Incubation
in primary antibodies were followed by the incubation in
secondary antibodies (donkey anti-rabbit Cy3 labeled and
donkey anti-mouse FITC labeled, 1:200, respectively).
Nucleus staining was performed with DAPI. Digital mi-
croscopy was performed with a Zeiss Axioscope micro-
scope equipped with a digital CCD camera (AxioCam and
AxioVision 4.8 software, Zeiss, Germany) or Leica con-
focal microscope (Leica-Microsystems, Germany).
A positive co-localization was considered by the
appeared yellow (red + green) profiles in merged im-
ages, similar in size, shape and geometry in red and
green profiles.
Cells, immunoblot analysis and immunoprecipitation
Primary astrocytes were cultured from the neonatal rats,
as described previously [57]. In brief, removed brain cor-
tices were triturated in minimal essential medium
(MEM; Sigma, St. Louis, MO, USA) containing 10% fetal
bovine serum (FBS; HyClone, Logan, UT, USA), plated
in 75 cm2 T-flasks, and incubated for 2–3 weeks. Micro-
glia were detached from flasks by mild shaking, and pri-
mary astrocytes remaining in the flask were harvested
with 0.1% trypsin. Astrocytes were plated in 100-mm
dishes, and cultured in MEM containing 10% FBS.
Primary astrocytes and a human embryonic kidney
(HEK) 293 cells stably expressing the IL-1 receptor and
toll-like receptor 4 (293/IL-1R/TLR4) were maintained
at 37 °C in a humidified incubator contain 5% CO2. For
the knockdown experiments, cells were transfected with
50 pmol of rat APE1/Ref-1 or human APE1/Ref-1 (Bio-
neer, South Korea, 1006541)-specific siRNA (siRef-1)
using Lipofectamine 2000 reagent (Invitrogen) according
to manufacturer’s instruction. For the ectopic expres-
sion, cells were transfected with wild-type APE1/Ref-1
(WT-Ref-1) or ΔNLS-Ref-1 in DsRed expression vector
[58]. ΔNLS-Ref-1 encodes APE1/Ref-1 with a 28-aa de-
letion of the putative N-terminal nuclear localization
signal [16]. Alternatively, cells were infected with re-
combinant virus encoding β-galactosidase (Adβgal) or
full-length APE1/Ref-1 (AdRef-1) with the titers of 200
PFU per cells [58].
After treatment as described in the figure legends, cells
were collected and lysed. Cell lysates were fractionated
by 10% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) and visualized by enhanced chemiluminescence
according to the manufacturer’s instruction (Amersham).
For immunoprecipitation assays, the lysates were mixed
and precipitated with the relevant antibody and protein
G-A agarose beads by overnight incubation at 4 °C. The
bound proteins were resolved in 10% SDS-PAGE for im-
munoblot analysis.
IKK kinase assay
Whole cell extracts were immunoprecipitated with an
anti-IKKγ antibody, and protein A agarose beads by in-
cubation at 4 °C for 4 h to overnight. The beads were
washed with lysis buffer, and kinase assay was then per-
formed in complete kinase assay buffer (20 mM HEPES
at pH 7.5, 20 mM β-glycerol phosphate, 10 mM MgCl2,
1 mM DTT, 10 mM PNPP, 50 μM sodium vanadate,
20 μM ATP) with the addition of [γ-32P]-ATP and 1 μg
of GST-IκBα (1-54) substrate. After 20 min at 30 °C,
sample buffer was added and proteins were resolved in
12% SDS-polyacrylamide gels, and phosphorylated sub-
strates were visualized by autoradiography.
Luciferase reporter assay
293/IL-1R/TLR4 cells were co-transfected with p2xNF-
κB-Luc, p2xTRE-Luc, pRSV-β-galactosidase, with or
without of WT-Ref-1, ΔNLS-Ref-1 expression vector as
indicated figure legends using Lipofectamine reagent ac-
cording to the manufacturer’s instructions (Invitrogen).
Twenty-four hours after transfection, cells were treated
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with LPS (1 μg/ml) for additional 10 h, and luciferase activ-
ities were measured using a luciferase assay kit (Promega,
Madison, CA, USA). Luciferase activity was normalized
relative to β-galactosidase activity of each sample.
Determination of Intracellular ROS levels
The levels of intracellular ROS were measured using
fluoresecent dye 2,7-dichlorofluorescein diacetate (DCF-
DA). Cells were stained with 1 μM CM-H2DCFDA
(Invitrogen Life Technologies, C6827) in Hank’s bal-
anced salt solution for 30 min. Then cells were fixed
with 4% paraformaldehyde before collecting cells. The
stained cells were analyzed with FACSCanto II flow cyt-
ometer, and data were processed with the FlowJo soft-
ware (FLOWJO).
Assay for TNF-α secretion
TNF-α was measured by an enzyme linked immuno-
sorbent assay (ELISA) according to the manufacturer’s
instruction. Cells (2 x 105 cells/well) were incubated for
24 h in medium alone or in medium containing LPS
(1 μg/mL). The supernatants were collected and frozen
at -80 °C until assayed for TNF-α.
Statistical analysis
Numerical data are presented as mean ± SEM. Statistical
significance of the data between groups was determined
by using independent Student’s t-test. Analysis of vari-
ance (ANOVA), followed by post-hoc tests, was also
used as needed.
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